FDA Disclosure of Safety and Efficacy Data: The Scope of Section 301(j)

Authors

Richard S. Fortunato

Keywords

301(j), FDA, drug, commerce, consumer

Recommended Citation

Richard S. Fortunato, FDA Disclosure of Safety and Efficacy Data: The Scope of Section 301(j), 52 Fordham L. Rev. 1280 (1984).
Available at: https://ir.lawnet.fordham.edu/flr/vol52/iss6/30